Supplementary Material from Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells &lt;i&gt;in vitro&lt;/i&gt; via suppression of c-FLIP-s levels and activation of CD95